logo
Afternoon napping could have surprising impact on longevity, study suggests

Afternoon napping could have surprising impact on longevity, study suggests

Fox News01-07-2025
A new study linking daytime napping to increased mortality rates in older adults may have some rethinking that midday snooze.
The study, presented last month at SLEEP 2025, the 39th annual meeting of the Associated Professional Sleep Societies in Seattle, Washington, found that frequent, longer and irregular daytime naps — especially in the early afternoon — were linked to a higher risk of death over an eight-year period.
"Our study fills a gap in knowledge," lead author Chenlu Gao, a postdoctoral research fellow at Massachusetts General Hospital in Boston, told Fox News Digital.
The research shows "not just whether someone naps, but how long, how variable, and when they nap during the day may be meaningful indicators of future health risk," he said.
The study included 86,565 participants averaging 63 years of age — all of whom worked regular daytime schedules — who were monitored by actigraphy, which detects movement during sleep but not brain activity.
Scientists defined daytime napping as sleeping between 9 a.m. and 7 p.m.
After the initial study, researchers kept tabs on the participants for eight years and discovered that 5,189 (6.0%) of them died during that time period.
The research showed that taking longer naps — and napping between 11 a.m. and 1 p.m. or between 1 p.m. and 3 p.m. — was associated with a higher mortality rate.
Results were adjusted for other potential factors influencing mortality, like demographics, weight, smoking, alcohol consumption and nighttime sleep duration, the researchers stated.
"Naps are not necessarily problematic unless they are used to compensate for chronically poor sleep at night," Dr. Chelsie Rohrscheib, a neuroscientist and sleep specialist at Wesper in New York, told Fox News Digital.
"Getting seven to nine hours of good quality sleep is required to maintain health and reduce the risk of developing dangerous medical conditions like heart disease and diabetes," added Rohrscheib, who was not involved in the study.
"Naps are not necessarily problematic unless they are used to compensate for chronically poor sleep at night."
The study did not establish proof that naps directly affect the risk of death.
"These are associations," Gao told Fox News Digital. "We cannot conclude from this study whether napping causes poor health."
In another potential limitation, because the study relied on detecting movement but not brain activity, "quiet wakefulness" may have been misclassified as sleep.
Additionally, defining daytime napping as sleep between 9 a.m. and 7 p.m. could have mistakenly included participants' actual sleep, affecting the accuracy of what would count as a nap, the researchers stated.
Excessive napping could also be a marker of other health issues, such as chronic disease, systemic inflammation, or disruptions to circadian rhythms, which may themselves increase mortality risk.
"Someone who requires daily naps to get through the day is likely not getting sufficient sleep during the night, or has an underlying health condition that causes daytime sleepiness," Rohrscheib noted.
Gao added, "We need more research to understand the causal relationships before we can conclude that a certain type of napping pattern would benefit health."
"However, we suggest that monitoring napping patterns might help us identify health conditions early, so that we can implement interventions accordingly."
The American Academy of Sleep Medicine encourages healthy adults to limit naps to no longer than 20 to 30 minutes in the early afternoon.
While a brief "power nap" can improve daytime alertness and performance, naps of 30 minutes or longer may cause a person to feel groggy after waking up. This grogginess, or "sleep inertia," can delay the short-term benefits of a nap, experts say.
For more Health articles, visit www.foxnews.com/health
Overall, the findings suggest that when it comes to mid-day snoozing, moderation is key — and that napping patterns could be a window into broader health concerns worth discussing with a medical provider.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

A salty twist: Diabetes risk study says french fries are a culprit
A salty twist: Diabetes risk study says french fries are a culprit

Yahoo

time16 minutes ago

  • Yahoo

A salty twist: Diabetes risk study says french fries are a culprit

Craving french fries? Dunking your spuds in a deep fryer might be a recipe for elevating your risk of Type 2 diabetes. According to a study published Wednesday in the journal BMJ, swapping out your weekly dose of frites for boiled, baked or mashed potatoes could lower your risk of this chronic condition. The authors examined the diets of more than 205,000 adults in the U.S. who responded to questionnaires about what they ate over nearly four decades. Among those who consumed potatoes, the authors looked at which people developed Type 2 diabetes, a disease that leads to persistently high blood sugar levels. Eating three weekly servings of french fries, they found, was associated with a 20% increased risk of Type 2 diabetes. But consuming the same amount of boiled, baked or mashed potatoes did not appear to be linked to the disease. The vast majority of the 1 in 10 people with diabetes in the U.S. have Type 2. The condition can increase the risk of heart attacks, strokes or kidney damage. The findings underscore that the way foods are prepared is key to their overall health risks or benefits, said Seyed Mohammad Mousavi, the study's lead author and a postdoctoral research fellow at the Harvard T.H. Chan School of Public Health. 'Not all potatoes are created equal,' he said. 'Even a small amount of french fries, less than one serving in the week, is associated with a higher risk of Type 2 diabetes.' Unlike boiled or baked potatoes, french fries are deep-fried in oils that usually contain trans or saturated fats. The way the body metabolizes those fats can contribute to insulin resistance — when cells don't respond properly to insulin, a hormone that helps regulate blood sugar. Regular consumption of fried foods can also lead to obesity and inflammation, both of which raise the risk of Type 2 diabetes. 'When you fry the potatoes, the energy content — calories — increases because of the fat they absorb. If you eat many servings of french fries, it predisposes [people] to weight gain,' said Candida Rebello, the director of the nutrition and chronic disease program at Louisiana State University, who wasn't involved in the study. The study relied on data collected between 1984 and 2021, when several different frying methods were popular. Most fast-food chains today prepare fries using vegetable oils like canola, sunflower, soybean or peanut oil. But during the 1980s, beef tallow was common. And in the early 1990s, restaurants shifted to partially hydrogenated oils. (The oils were a major source of trans fat in the U.S. diet and were largely phased out of the food industry by 2018.) Health and Human Services Secretary Robert F. Kennedy Jr. has said the seed oils used today are 'poisoning' Americans and contributing to high levels of obesity in children. He has advocated for restaurants to switch back to beef tallow, a recommendation that isn't backed by scientific research. 'Beef tallow is high in saturated fats and other harmful fats. We definitely don't recommend that,' Mousavi said. One limitation of Mousavi's study is that it did not account for people adding unhealthy ingredients to their boiled, baked or mashed potatoes. 'What do people add to baked potatoes? Butter, bacon, cheese, sour cream,' said Shannon Galyean, an assistant professor of nutritional sciences at Texas Tech University, who wasn't part of the research. 'Then we also don't know, did they eat it with the skins?' Galyean said potato skins contain nutrients such as fiber, which helps with blood sugar control. And potatoes, when they aren't deep-fried or slathered in butter, can be a useful source of potassium, which helps regulate blood pressure. 'Definitely, potatoes can be considered a healthy food when you don't fry it, or when you don't add lots of fat to it,' Galyean said. Mousavi said baking french fries at home with a healthier oil, such as olive or avocado oil, could help lower one's diabetes risk compared to eating them from fast-food restaurants. Swapping out potatoes with whole grains, such as farro or whole-grain bread or pasta, could make an even bigger difference. These foods have a lower glycemic index, meaning they're less likely to spike blood sugar levels. His study found that whole grains, when compared to all types of potatoes, were less likely to elevate one's diabetes risk. White rice, on the other hand, had a stronger association with Type 2 diabetes than either of these foods. Megan Mulcahy, the director of communications at Potatoes USA, a marketing and research organization that supports potato consumption, said fries can 'absolutely be part of a healthy eating pattern when enjoyed in moderation.' Galyean said it's important to consider a person's overall diet, which has a greater impact on their health than any individual food. Nutritionists generally recommend a colorful plate with a variety of fruits, vegetables, whole grains and healthy proteins such as fish, beans or nuts. 'People don't eat just one thing, they eat meals,' Galyean said. This article was originally published on Solve the daily Crossword

NASA's Butch Wilmore retires from astronaut corps after spending 9 unexpected months in space
NASA's Butch Wilmore retires from astronaut corps after spending 9 unexpected months in space

CNN

time17 minutes ago

  • CNN

NASA's Butch Wilmore retires from astronaut corps after spending 9 unexpected months in space

Astronaut Butch Wilmore is retiring from NASA less than five months after he returned from a troubled test mission that left him aboard the International Space Station far longer than expected, the space agency announced Wednesday. Wilmore, along with NASA astronaut Suni Williams, piloted the first crewed flight of Boeing's Starliner spacecraft last year. The mission gained worldwide attention when the spacecraft experience several serious issues en route to the space station, including thruster outages and gas leaks. Williams and Wilmore had been expected to stay about eight days in orbit. But NASA and Boeing spent weeks attempting to pinpoint what went wrong with their vehicle and assessing whether Starliner was safe to carry the astronauts home. The space agency ultimately decided returning the duo to Earth aboard Starliner was too risky a proposition. NASA announced last August that Williams and Wilmore would join the next International Space Station crew rotation along with two other astronauts on SpaceX's Crew-9 mission and remain aboard the orbiting laboratory for several additional months. Williams and Wilmore ultimately returned home in March — more than nine months after they left Earth. Such a duration of stay in orbit is not uncommon, as astronauts routinely live on the space station for six months or longer when they serve on staff rotation missions. Both astronauts have maintained the position that they were fully prepared for their extended stay in space, saying they each understood the risks and uncertainty associated with test flying a spacecraft for the first time. Williams and Wilmore also repeatedly sought to quash narratives that they were 'abandoned,' 'stuck' or 'stranded' in space. 'That's been the narrative from day one: stranded, abandoned, stuck — and I get it, we both get it,' Wilmore told CNN's Anderson Cooper in February. 'Help us change the narrative, let's change it to: prepared and committed despite what you've been hearing. That's what we prefer.' Wilmore's 'commitment to NASA's mission and dedication to human space exploration is truly exemplary,' said Steve Koerner, the acting head of NASA's Johnson Space Center in Houston, where astronauts train, in a statement Wednesday. 'His lasting legacy of fortitude,' Koerner added, 'will continue to impact and inspire the Johnson workforce, future explorers, and the nation for generations.' Wilmore's departure from NASA follows the example set by Bob Behnken and Doug Hurley, the two astronauts who piloted the first crewed test flight of SpaceX's Crew Dragon capsule in 2020. That mission marked the last for both Behken and Hurley, who have each since retired. Wilmore, a Naval officer and test pilot who served in 21 combat missions, joined NASA's astronaut corps in 2000. He flew on three missions during his 25 years of service, including a mission on the space shuttle Atlantis and a trip to the space station on a Russian Soyuz spacecraft. Notably, upon his return to Earth on a SpaceX capsule in March, Wilmore said that he would theoretically fly aboard one of Boeing's Starliner capsules again if given the opportunity. 'We're going to rectify all the issues that we encountered. We're going to fix them, we're going to make it work,' Wilmore said during a March 31 news conference. 'And with that, I'd get on in a heartbeat.' Sign up for CNN's Wonder Theory science newsletter. Explore the universe with news on fascinating discoveries, scientific advancements and more.

Minnesota sees sedative overdose spike: "Naloxone isn't going to help"
Minnesota sees sedative overdose spike: "Naloxone isn't going to help"

CBS News

time19 minutes ago

  • CBS News

Minnesota sees sedative overdose spike: "Naloxone isn't going to help"

By WCCO reporter Ashley Grams The Minnesota Department of Health issued a health advisory last week warning of an increase in overdose cases involving sedatives. Data collected by the department's Minnesota Drug Overdose and Substance Use Surveillance Activity (MNDOSA) project shows just one overdose case where the sedative xylazine was detected. That number jumped to 53 in 2024. Now, the state is tracking another sedative emerging in the drug supply. "Medetomidine, it has been seen in other parts of the country," said Deepa McGriff, the department's epidemiologist supervisor. "It is a veterinary sedative that's not approved for human use, and in 2025 we started to see more detections." The state's Public Health Laboratory started tracking medetomidine in 2024 and this year has seen 12 cases. "Here in Minnesota, we are somewhat insulated, initially, from new substances as they emerge, maybe on the East Coast or West Coast," said Jason Peterson, who supervises the chemical threats and bio monitoring units at the Public Health Laboratory. Peterson says medetomidine was "starting to grow" out on the East Coast. "They do take delays in a lot of times in entering our state, but we are mindful of that and we are mindful of the patterns where drugs typically flow across the country," he said. This increase in sedatives is a dangerous reality for drug users across the state. "Certainly for the subset of people that we work with that are using substances, we do see these things come through," said John Tribbett, the service area director for Avivo's ending homelessness division. "We are at a point unfortunately where you never know what people are getting, and what they end up putting in their body. Tribbett said all of Avivo's teams are trained in overdose reversal. The state's health advisory warns that these sedatives "significantly complicates the treatment of overdose patients." McGriff says the department wants the community and first responders to understand that sedatives may be a factor in an overdose, and how that can impact treatment. "If there's a sedative involved, the Naloxone isn't going to work to reverse that unresponsiveness," McGriff said. "We want to emphasize the need to focus on restoring the breathing of the overdose patients, rather than restoring the consciousness." McGriff said an opioid reversal drug like naloxone should still be used in these cases. Tribbett believes the emergence of medetomidine is a reflection of policy aimed at restricting xylazine. "What we see time and time again is a crackdown on one particular chemical, and then something emerges to replace it," Tribbett said. Some states have made an effort to limit access to xylazine in recent years, including Pennsylvania, which classified xylazine as a Schedule 3 drug. Minnesota's health department says data is still limited when it comes to medetomidine, but awareness is important — something Tribbett agrees with. "Making people aware, helping our teams have the information they need, helping people in the community know what's out there," Tribbett said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store